The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of a multigene prognostic assay on postoperative management of early-stage non-small cell lung cancer.
Shane Dormady
No relevant relationships to disclose
Thierry Jahan
No relevant relationships to disclose
Michael J. Mann
Consultant or Advisory Role - Life Technologies; Pinpoint Genomics
David Jablons
Consultant or Advisory Role - Life Technologies; Pinpoint Genomics
Michael S. Broder
No relevant relationships to disclose
Alison H. DeCristofaro
No relevant relationships to disclose
Ayanna Anene
No relevant relationships to disclose